Second RSV Vaccine Lands Approval for Older Adults
(MedPage Today) -- The FDA has approved a second respiratory syncytial virus (RSV) vaccine for preventing lower respiratory infections in adults 60 and over, Pfizer announced on Wednesday.
Approval of the unadjuvanted, bivalent RSV prefusion F...
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: American Health | International Medicine & Public Health | Pfizer | Respiratory Medicine | Vaccines